Los Angeles Capital Management LLC Sells 1,957 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Los Angeles Capital Management LLC trimmed its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 15.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,535 shares of the company’s stock after selling 1,957 shares during the quarter. Los Angeles Capital Management LLC owned 0.06% of Addus HomeCare worth $978,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of ADUS. GAMMA Investing LLC acquired a new stake in Addus HomeCare during the fourth quarter worth about $34,000. Assetmark Inc. raised its stake in shares of Addus HomeCare by 17.1% in the third quarter. Assetmark Inc. now owns 1,331 shares of the company’s stock valued at $113,000 after purchasing an additional 194 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new position in Addus HomeCare in the third quarter worth $189,000. Cetera Trust Company N.A acquired a new stake in Addus HomeCare during the fourth quarter worth $219,000. Finally, Heritage Wealth Management LLC bought a new stake in Addus HomeCare in the 4th quarter valued at $222,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Price Performance

Shares of ADUS stock opened at $106.10 on Friday. The stock’s fifty day moving average is $99.31 and its 200-day moving average is $92.81. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. Addus HomeCare Co. has a 52 week low of $78.35 and a 52 week high of $107.54. The stock has a market capitalization of $1.74 billion, a PE ratio of 26.33, a PEG ratio of 1.94 and a beta of 0.96.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, May 6th. The company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The firm had revenue of $280.70 million for the quarter, compared to analyst estimates of $279.49 million. During the same quarter in the prior year, the firm earned $0.84 EPS. The company’s revenue was up 11.6% on a year-over-year basis. Equities research analysts expect that Addus HomeCare Co. will post 4.38 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently commented on ADUS. William Blair reaffirmed an “outperform” rating on shares of Addus HomeCare in a report on Monday, February 5th. Bank of America lifted their price objective on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday. Oppenheimer reissued an “outperform” rating and issued a $118.00 target price on shares of Addus HomeCare in a report on Tuesday, March 26th. Barclays lowered Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a research note on Tuesday, April 23rd. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $102.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 29th. One analyst has rated the stock with a sell rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $108.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.